These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 25485803

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Safety, Efficacy, and Patient Satisfaction With OnabotulinumtoxinA for the Treatment of Upper Facial Lines in Japanese Subjects.
    Kawashima M, Harii K, Horiuchi Y, Seidman E, Lei X, Hopfinger R, Lee E.
    Dermatol Surg; 2020 Apr; 46(4):483-490. PubMed ID: 31517663
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of OnabotulinumtoxinA treatment for crow's feet lines on patient-reported outcomes.
    Dayan S, Coleman WP, Dover JS, De Boulle K, Street J, Romagnano L, Daniels S, Kowalski JW, Lei X, Lee E.
    Dermatol Surg; 2015 Jan; 41 Suppl 1():S67-74. PubMed ID: 25548848
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. OnabotulinumtoxinA (Botox) in the Treatment of Crow's Feet Lines in Japanese Subjects.
    Harii K, Kawashima M, Furuyama N, Lei X, Hopfinger R, Lee E.
    Aesthetic Plast Surg; 2017 Oct; 41(5):1186-1197. PubMed ID: 28733805
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High Patient Satisfaction for up to 6 Months With OnabotulinumtoxinA Treatment for Upper Facial Lines.
    Cohen JL, Fagien S, Ogilvie P, De Boulle K, Carruthers J, Cox SE, Kelly R, Garcia JK, Sangha S.
    Dermatol Surg; 2022 Nov 01; 48(11):1191-1197. PubMed ID: 36342250
    [Abstract] [Full Text] [Related]

  • 16. Phase I/III Clinical Trial to Evaluate the Safety and Efficacy of a New Botulinum Toxin (HU-014) Versus OnabotulinumtoxinA in Subjects With Moderate-to-Severe Crow's Feet Lines.
    Han HS, Yoo KH, Lee JS, Huh CH, Kwon SH, Lee YW, Kim BJ.
    Dermatol Surg; 2021 Apr 01; 47(4):e127-e131. PubMed ID: 33795571
    [Abstract] [Full Text] [Related]

  • 17. OnabotulinumtoxinA for Simultaneous Treatment of Upper Facial Lines: Subject-Reported Satisfaction and Impact From a Phase 3 Study.
    Rivkin AZ, Ogilvie P, Dayan S, Yoelin SG, Weichman BM, Garcia JK.
    Dermatol Surg; 2020 Jan 01; 46(1):50-60. PubMed ID: 30829771
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Phase III, Non-Inferiority Study Comparing PrabotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
    Rzany BJ, Ascher B, Avelar RL, Bergdahl J, Bertucci V, Bodokh I, Carruthers JA, Cartier H, Delmar H, Denfeld R, Gross JE, Heckmann M, Hedén P, Hilton S, Inglefield C, Ogilvie P, Sattler G, Sebastian M, Solish N, Swift A, Trévidic P.
    Aesthet Surg J; 2020 Mar 23; 40(4):413-429. PubMed ID: 30951166
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.